|  | 
27 - November 30, 2012 in Kiev ("KPI", Engineering Physics Department) was held international conference "Powder Metallurgy: today and tomorrow" is dedicated to the sixtieth of Frantsevich Institute for Problems of Materials Science of NASU, National Academy of Science, Ukraine
Conference PM 2012 "Powder Metallurgy: today and tomorrow"
PM 2012 conference focused on the following issues: fundamental problems of the powders, the processes of powder materials formation, the influence of the solid-and liquid-phase sintering of powder on the products properties, technology of powder products obtaining, and nanotechnologies in powder metallurgy, the high-pressure, abrasive materials, testing the powder materials properties.
At the conference Director of Materials Research Centre Oleksiy Gogotsi presented a report
11Materials Research Centre Ltd., 03680 Kiev, st. Krzhizhanovskogo, 3, Ukraine;
 2 Frantsevich Institute for Problems of Materials Science of NASU, National Academy of Science, 03142, Kiev, st. Krzhizhanovskogo, 3, Ukraine;
 3 National Metallurgic Academy of Ukraine (NMetAU), 49600, Dniepropetrovsk, str. Gagarina, 4, Ukraine;
4 American Energy Technologies Co., 60026, Glenview, IL, USA, 
5 Argonne National Laboratory, 60439, Argonne, IL, USA,
While developing a complex of equipment, ordered by American Energy Technologies Co, for the processing and receiving of graphitized and partially graphitized pure carbon materials, there was a problem to choose the thickness of details and parts of equipment. That equipment can be under the influence of the coke particles flow, moving at different speeds and acting with different pressures. Also there was a need to compare wear of ordinary structural steel 3 and stainless steel AISI 304.
Wear of steel parts is well simulated by abrasive wear test, that was done on the immovable ring type facility.
Read more about Testing of the material samples on the abrasive wear >>
The research group is grateful for project developing to US Department of Energy, DoE , Regina Carter, GIPP, US National Nuclear Security Administration, Ukrainian Science and Technology Centre (STCU), represented by Vic Korsun, STCU US Deputy Executive Director, and Irina Tomashevskaya.

 










 
  MXenes potential applications include sensors, wound healing materials, and drug delivery systems. A recent study explored how different synthesis methods affect the safety and performance of MXenes. By comparing etching conditions and intercalation strategies, researchers discovered that fine-tuning the surface chemistry of MXenes plays a crucial role in improving biocompatibility. These results provide practical guidelines for developing safer MXenes and bring the field one step closer to real biomedical applications.
MXenes potential applications include sensors, wound healing materials, and drug delivery systems. A recent study explored how different synthesis methods affect the safety and performance of MXenes. By comparing etching conditions and intercalation strategies, researchers discovered that fine-tuning the surface chemistry of MXenes plays a crucial role in improving biocompatibility. These results provide practical guidelines for developing safer MXenes and bring the field one step closer to real biomedical applications.
 Exellent news, our joint patent application with Drexel University on highly porous MAX phase precursor for MXene synthesis published. Congratulations and thanks to all team involved!
Exellent news, our joint patent application with Drexel University on highly porous MAX phase precursor for MXene synthesis published. Congratulations and thanks to all team involved! Last Call! Have you submitted your abstract for IEEE NAP-2025 yet? Join us at the International Symposium on "The MXene Frontier: Transformative Nanomaterials Shaping the Future" – the largest MXene-focused conference in Europe this year!  Final Submission Deadline: May 15, 2025. Don’t miss this exclusive opportunity to showcase your research and engage with world leaders in the MXene field!
Last Call! Have you submitted your abstract for IEEE NAP-2025 yet? Join us at the International Symposium on "The MXene Frontier: Transformative Nanomaterials Shaping the Future" – the largest MXene-focused conference in Europe this year!  Final Submission Deadline: May 15, 2025. Don’t miss this exclusive opportunity to showcase your research and engage with world leaders in the MXene field! We are excited to announce the publication of latest review article on MXenes in Healthcare. This comprehensive review explores the groundbreaking role of MXenes—an emerging class of 2D materials—in revolutionizing the fields of medical diagnostics and therapeutics.  Read the full article here: https://doi.org/10.1039/D4NR04853A.
We are excited to announce the publication of latest review article on MXenes in Healthcare. This comprehensive review explores the groundbreaking role of MXenes—an emerging class of 2D materials—in revolutionizing the fields of medical diagnostics and therapeutics.  Read the full article here: https://doi.org/10.1039/D4NR04853A. Congratulations and thank you to our collaborators from TU Wien and CEST for very interesting work and making it published! In this work, an upscalable electrochemical MXene synthesis is presented. Yields of up to 60% electrochemical MXene (EC-MXene) with no byproducts from a single exfoliation cycle are achieved.
Congratulations and thank you to our collaborators from TU Wien and CEST for very interesting work and making it published! In this work, an upscalable electrochemical MXene synthesis is presented. Yields of up to 60% electrochemical MXene (EC-MXene) with no byproducts from a single exfoliation cycle are achieved. Congratulations to all collaborators with this interesting joint work!
Congratulations to all collaborators with this interesting joint work! Thank you to our collaborators for the amazing joint work recently published in Graphene and 2D Nanomaterials about  MXene–silk fibroin composite films aiming to develop materials with tunable electronic and thermal properties
Thank you to our collaborators for the amazing joint work recently published in Graphene and 2D Nanomaterials about  MXene–silk fibroin composite films aiming to develop materials with tunable electronic and thermal properties Dr. Oleksiy Gogotsi, director of MRC and Carbon-Ukraine, innovative companies that are among the leaders on the world MXene market, visited 2024 MRS Fall Meeting & Exhibit. together with Dr. Maksym Pogorielov, Head of Advanced Biomaterials and Biophysics Laboratory, University of Latvia.
Dr. Oleksiy Gogotsi, director of MRC and Carbon-Ukraine, innovative companies that are among the leaders on the world MXene market, visited 2024 MRS Fall Meeting & Exhibit. together with Dr. Maksym Pogorielov, Head of Advanced Biomaterials and Biophysics Laboratory, University of Latvia.
 MRC and Carbon-Ukraine team visited the 3rd International MXene conference held at Drexel University on August 5-8, 2024. Conference brought together the best reserchers and leading experts on MXene field.
MRC and Carbon-Ukraine team visited the 3rd International MXene conference held at Drexel University on August 5-8, 2024. Conference brought together the best reserchers and leading experts on MXene field. 
 Together with colleagues from the University of Latvia, MRC/Carbone Ukraine, Adam Mickiewicz University, University Clinic Essen, and others, we have developed a novel concept involving the binding of antibodies to MXenes. In our research, we utilized anti-CEACAM1 antibodies to develop targeted photo-thermal therapy for melanoma (in vitro), paving the way for future in vivo studies and clinical trials. For the first time, we demonstrate the feasibility of delivering MXenes specifically targeted to melanoma cells, enabling the effective ablation of cancer cells under near-infrared (NIR) light. This new technique opens up vast potential for the application of MXenes in cancer treatment, diagnostics, drug delivery, and many other medical purposes.
Together with colleagues from the University of Latvia, MRC/Carbone Ukraine, Adam Mickiewicz University, University Clinic Essen, and others, we have developed a novel concept involving the binding of antibodies to MXenes. In our research, we utilized anti-CEACAM1 antibodies to develop targeted photo-thermal therapy for melanoma (in vitro), paving the way for future in vivo studies and clinical trials. For the first time, we demonstrate the feasibility of delivering MXenes specifically targeted to melanoma cells, enabling the effective ablation of cancer cells under near-infrared (NIR) light. This new technique opens up vast potential for the application of MXenes in cancer treatment, diagnostics, drug delivery, and many other medical purposes.
